Skip to content

Flow MRI in Normal Pressure Hydrocephalus

Benefit of Flow Magnetic Resonance Imaging in the Management of Normal Pressure Hydrocephalus

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01909960
Acronym
HydroFlux
Enrollment
144
Registered
2013-07-29
Start date
2012-05-03
Completion date
2020-08-18
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Pressure Hydrocephalus

Keywords

Normal pressure hydrocephalus, Flow MRI, Dementia, Cerebrospinal fluid, Shunt

Brief summary

Normal pressure hydrocephalus diagnosis based on quantitative study of cerebro-spinal fluid and blood flow by phase contrast magnetic resonance imaging.

Interventions

Quantitative flow study was performed by 2D phase-contrast velocity-encoded cine MRI (repetition/echo time, 15/7 ms; field of view = 140 x 140 mm²; matrix size = 256 x 128, flip angle = 25 degrees,one excitation, slice thickness = 5 mm). Cerebrospinal fluid and blood flows are measured with a velocity-encoding value of 5-10 cm/s and 80 cm/s respectively. Peripheral gating was used to cover the entire cardiac cycle with retrospective cardiac synchronization of 32 quantitative flow-encoded images per cycle. Clinical examination consists in Larson's score and MMSE

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ventricular dilation seen on morphological magnetic resonance imaging (MRI) * Walking disorder * Cognitive disorder * Participants gave their written informed consent

Exclusion criteria

* Contra-indication to MRI * Obstructive tumoral hydrocephalus * Curatorship or tutorship * Pregnancy or lactation * No social assurance

Design outcomes

Primary

MeasureTime frameDescription
cerebrospinal fluid (CSF) stroke volume evolution other 6 monthsDay 1 (baseline), Day 180Measurement of cerebrospinal fluid (CSF) stroke volume via flow MRI at the Sylvius' aqueduct, pontine cistern and spinal spaces levels and determination of its evolution

Secondary

MeasureTime frameDescription
Blood flow analysis : evolution other 6 monthsDay 1 (baseline), Day 180Assessment of arterial (internal carotids and cerebral arteries) and venous (sagittal sinus, straight sinus) blood flow in terms of mean cerebral blood outflow and stroke volume and determination of blood flow evolution.
Larson's score evolution over 6 monthsDay 1, Day 180Record symptoms on walking, living conditions and urinary disorders
Neuropsychological test evolution over 6 monthsDay1, Day 180Consists in mini mental status evaluation (MMSE) for cognitive evaluation
Blood flow analysis : evolution other one yearDay 1 (baseline) and Day 365Assessment of arterial (internal carotids and cerebral arteries) and venous (sagittal sinus, straight sinus) blood flow in terms of mean cerebral blood outflow and stroke volume and determination of blood flow evolution.
Larson's score evolution over one yearDay 1 and Day 365Record symptoms on walking, living conditions and urinary disorders
Neuropsychological test evolution over one yearDay1, Day 365Consists in mini mental status evaluation (MMSE) for cognitive evaluation
cerebrospinal fluid (CSF) stroke volume evolution other one yearDay1 (baseline), Day 365Measurement of cerebrospinal fluid (CSF) stroke volume via flow MRI at the Sylvius' aqueduct, pontine cistern and spinal spaces levels and determination of its evolution

Countries

France

Contacts

PRINCIPAL_INVESTIGATOROlivier Balédent, PhD

CHU Amiens

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026